ATE542820T1 - Pteridinderivate als inhibitoren der polo-like- kinase zur behandlung von krebs - Google Patents
Pteridinderivate als inhibitoren der polo-like- kinase zur behandlung von krebsInfo
- Publication number
- ATE542820T1 ATE542820T1 AT07824247T AT07824247T ATE542820T1 AT E542820 T1 ATE542820 T1 AT E542820T1 AT 07824247 T AT07824247 T AT 07824247T AT 07824247 T AT07824247 T AT 07824247T AT E542820 T1 ATE542820 T1 AT E542820T1
- Authority
- AT
- Austria
- Prior art keywords
- optionally substituted
- ring
- polo
- treatment
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0621205A GB0621205D0 (en) | 2006-10-25 | 2006-10-25 | Inhibitors of PLK |
GB0715614A GB0715614D0 (en) | 2007-08-10 | 2007-08-10 | Inhibitors of plk |
PCT/GB2007/003998 WO2008050096A1 (en) | 2006-10-25 | 2007-10-19 | Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE542820T1 true ATE542820T1 (de) | 2012-02-15 |
Family
ID=38896021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07824247T ATE542820T1 (de) | 2006-10-25 | 2007-10-19 | Pteridinderivate als inhibitoren der polo-like- kinase zur behandlung von krebs |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100216802A1 (de) |
EP (1) | EP2079743B1 (de) |
JP (1) | JP2010507639A (de) |
KR (1) | KR20090071668A (de) |
AT (1) | ATE542820T1 (de) |
AU (1) | AU2007310604B2 (de) |
BR (1) | BRPI0718120A2 (de) |
CA (1) | CA2665736A1 (de) |
EA (1) | EA200900593A1 (de) |
IL (1) | IL198082A0 (de) |
MX (1) | MX2009004244A (de) |
NZ (1) | NZ577153A (de) |
WO (1) | WO2008050096A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0619753D0 (en) | 2006-10-06 | 2006-11-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
EA017198B1 (ru) * | 2006-10-30 | 2012-10-30 | Хрома Терапьютикс Лтд. | Гидроксаматы в качестве ингибиторов гистон-деацетилазы |
DE602007012473D1 (de) | 2006-12-14 | 2011-03-24 | Vertex Pharma | Als proteinkinaseinhibitoren geeignete verbindungen |
GB0803747D0 (en) | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
GB0807451D0 (en) * | 2008-04-24 | 2008-05-28 | Chroma Therapeutics Ltd | Inhibitors of PLK |
NZ590266A (en) | 2008-06-23 | 2012-08-31 | Vertex Pharma | Protein kinase inhibitors based on dihydro-5h-pyrimido[4,5-b]diazepin or dihydropteridin |
MX2011000021A (es) * | 2008-06-23 | 2011-02-24 | Vertex Pharma | Inhibidores de proteina cinasas. |
GB0903480D0 (en) | 2009-02-27 | 2009-04-08 | Chroma Therapeutics Ltd | Enzyme Inhibitors |
KR20120081119A (ko) * | 2009-09-04 | 2012-07-18 | 잘리커스 파마슈티컬즈 리미티드 | 통증 및 간질 치료를 위한 치환된 헤테로고리 유도체 |
CN102020643A (zh) * | 2009-09-22 | 2011-04-20 | 上海恒瑞医药有限公司 | 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用 |
GB201211310D0 (en) | 2012-06-26 | 2012-08-08 | Chroma Therapeutics Ltd | CSF-1R kinase inhibitors |
PL3222616T3 (pl) | 2012-10-17 | 2019-12-31 | Macrophage Pharma Limited | N-[2-{4-[6-amino-5-(2,4-difluorobenzoilo)-2-oksopirydyn-1(2h)-ylo]-3,5-difluorofenylo}etylo)-L-alaninian tert-butylu lub jego sól, hydrat lub solwat |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
WO2015116696A1 (en) | 2014-01-28 | 2015-08-06 | Massachusetts Institute Of Technology | Combination therapies and methods of use thereof for treating cancer |
MX2016009975A (es) * | 2014-01-31 | 2016-10-31 | Dana Farber Cancer Inst Inc | Derivados de dihidropteridinona y sus usos. |
WO2015117053A1 (en) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Diaminopyrimidine benzenesulfone derivatives and uses thereof |
WO2015117087A1 (en) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
AU2016319116B2 (en) | 2015-09-11 | 2020-10-01 | Dana-Farber Cancer Institute, Inc. | Cyano thienotriazolodiazepines and uses thereof |
KR20180081809A (ko) | 2015-11-25 | 2018-07-17 | 다나-파버 캔서 인스티튜트 인크. | 2가 브로모도메인 억제제 및 그의 용도 |
GB201713975D0 (en) | 2017-08-31 | 2017-10-18 | Macrophage Pharma Ltd | Medical use |
US11773096B2 (en) | 2018-08-10 | 2023-10-03 | Yale University | Small-molecule PI5P4K alpha/beta inhibitors and methods of treatment using same |
CN111039944B (zh) * | 2018-10-12 | 2021-11-23 | 中国科学院合肥物质科学研究院 | Mst1激酶抑制剂及其用途 |
KR102260995B1 (ko) * | 2018-11-28 | 2021-06-04 | 국립암센터 | Plk1의 활성 억제제를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물 |
CN115947728B (zh) * | 2021-10-09 | 2024-01-09 | 沈阳药科大学 | 含磺酰基的二氢喋啶酮衍生物及其应用 |
WO2023158514A1 (en) | 2022-02-18 | 2023-08-24 | Massachusetts Institute Of Technology | Cancer treatment by combined inhibition of polo-like kinase and microtubule polymerization |
CN118047779A (zh) * | 2022-11-09 | 2024-05-17 | 沈阳药科大学 | 含苯联杂芳基的二氢喋啶酮衍生物及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1632493A1 (de) * | 2004-08-25 | 2006-03-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
CA2575804A1 (en) * | 2004-08-26 | 2006-03-02 | Boehringer Ingelheim International Gmbh | Pteridinones used as plk (polo like kinase) inhibitors |
EP1784406A1 (de) * | 2004-08-27 | 2007-05-16 | Boehringer Ingelheim International GmbH | Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel |
-
2007
- 2007-10-19 AU AU2007310604A patent/AU2007310604B2/en not_active Ceased
- 2007-10-19 EA EA200900593A patent/EA200900593A1/ru unknown
- 2007-10-19 CA CA002665736A patent/CA2665736A1/en not_active Abandoned
- 2007-10-19 BR BRPI0718120-5A patent/BRPI0718120A2/pt not_active IP Right Cessation
- 2007-10-19 US US12/446,008 patent/US20100216802A1/en not_active Abandoned
- 2007-10-19 JP JP2009533934A patent/JP2010507639A/ja not_active Withdrawn
- 2007-10-19 KR KR1020097010620A patent/KR20090071668A/ko not_active Application Discontinuation
- 2007-10-19 EP EP07824247A patent/EP2079743B1/de not_active Not-in-force
- 2007-10-19 AT AT07824247T patent/ATE542820T1/de active
- 2007-10-19 MX MX2009004244A patent/MX2009004244A/es not_active Application Discontinuation
- 2007-10-19 WO PCT/GB2007/003998 patent/WO2008050096A1/en active Application Filing
- 2007-10-19 NZ NZ577153A patent/NZ577153A/en not_active IP Right Cessation
-
2009
- 2009-04-07 IL IL198082A patent/IL198082A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2010507639A (ja) | 2010-03-11 |
AU2007310604A1 (en) | 2008-05-02 |
MX2009004244A (es) | 2009-05-14 |
EA200900593A1 (ru) | 2010-06-30 |
NZ577153A (en) | 2012-02-24 |
IL198082A0 (en) | 2009-12-24 |
KR20090071668A (ko) | 2009-07-01 |
CA2665736A1 (en) | 2008-05-02 |
WO2008050096A1 (en) | 2008-05-02 |
BRPI0718120A2 (pt) | 2013-11-12 |
AU2007310604B2 (en) | 2012-02-02 |
EP2079743B1 (de) | 2012-01-25 |
EP2079743A1 (de) | 2009-07-22 |
US20100216802A1 (en) | 2010-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE542820T1 (de) | Pteridinderivate als inhibitoren der polo-like- kinase zur behandlung von krebs | |
PE20220931A1 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
BR0316146A (pt) | Derivados de amida do ácido 3-(2-hidróxifenil)-1h-pirazol-4-carboxìlico como inibidores de hsp90 para o tratamento de câncer | |
PE20151981A1 (es) | Pontenciador de inhibidores del homologo de zeste | |
PE20120506A1 (es) | Derivados de pirazolopiridina como inhibidores de quinasas | |
PE20120058A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
TW200714589A (en) | Phenylacetamides suitable as protein kinase inhibitors | |
NZ597983A (en) | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
TN2010000293A1 (en) | Thiazole derivatives used as pi 3 kinase inhibitors | |
AR077975A1 (es) | Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina | |
TW200942541A (en) | Polysubstituted 6-heteroarylimidazo[1,2-α]pyridine derivatives, preparation thereof and therapeutic use thereof | |
MY173930A (en) | Crystalline solvates and complexes of (is)-1,5-anhydro-1-c-(3-((phenyl)methyl)phenyl)-d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes | |
MX2009013218A (es) | Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus. | |
PE20130149A1 (es) | Derivados de la cromenona con actividad anti-tumoral | |
EA201101566A1 (ru) | Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ | |
PE20110213A1 (es) | Derivados de indolinona como inhibidores de quinasa | |
AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
MX2011009146A (es) | Sales de adicion de aminas que contienen grupos hidroxilo y/o carboxilicos con derivados de acido aminonicotinico como inhibidores de dhodh. | |
MX2010000658A (es) | Derivados de pirimidina 934. | |
IL198267A0 (en) | Ikk-?? serine-threonine protein kinase inhibitors | |
MX2021004380A (es) | Derivados de flavaglina para inhibicion de activacion del oncogen kras. | |
AR058329A1 (es) | Derivados de pirazolo (4,3-c) piridina sustituidos activos como inhibidores de quinasa, un metodo para su preparacion y composicion farmaceutica | |
DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
PH12018502411A1 (en) | Novel 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one derivative |